| Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients | |
| Ma, Shujuan; Zheng, Yixiang; Xiao, Yanni; Zhou, Pengcheng; Tan, Hongzhuan* | |
| 刊名 | Medicine (United States)
 |
| 2017 | |
| 卷号 | 96期号:19页码:e6888 |
| 关键词 | diabetes mellitus liver cancer meta-analysis metformin |
| ISSN号 | 0025-7974 |
| DOI | 10.1097/MD.0000000000006888 |
| URL标识 | 查看原文 |
| WOS记录号 | WOS:000401188600061 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3331028 |
| 专题 | 中南大学 |
| 作者单位 | 1.[Xiao, Yanni 2.Ma, Shujuan 3.Tan, Hongzhuan] Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, 110 Xiangya Rd, Changsha 410007, Hunan, Peoples R China. |
| 推荐引用方式 GB/T 7714 | Ma, Shujuan,Zheng, Yixiang,Xiao, Yanni,et al. Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients[J]. Medicine (United States),2017,96(19):e6888. |
| APA | Ma, Shujuan,Zheng, Yixiang,Xiao, Yanni,Zhou, Pengcheng,&Tan, Hongzhuan*.(2017).Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients.Medicine (United States),96(19),e6888. |
| MLA | Ma, Shujuan,et al."Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients".Medicine (United States) 96.19(2017):e6888. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论